Hiroomi Tada - Sep 6, 2022 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role: Chief Medical Officer
Signature: /s/ Ali D. Fawaz, Attorney-in-Fact
Stock symbol: TYRA
Transactions as of: Sep 6, 2022
Transactions value $: $23,044
Form type: 4
Date filed: 9/8/2022, 05:52 PM
Previous filing: Nov 4, 2021
Next filing: Sep 19, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TYRA	Common Stock	Award	$23K	+2.7K	+3.47%	$8.53	80.6K	Mar 15, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TYRA	Stock Option (Right to Buy)	Award	$0	+110K		$0.00	110K	Sep 6, 2022	Common Stock	110K	$7.14	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
F2	1/48th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.